<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03449953</url>
  </required_header>
  <id_info>
    <org_study_id>COHO vOct2017</org_study_id>
    <nct_id>NCT03449953</nct_id>
  </id_info>
  <brief_title>Critical Care Outcomes of Hematologic Oncology Patients</brief_title>
  <acronym>COHO</acronym>
  <official_title>Critical Care Outcomes of Patients With Hematologic Malignancy and Hematopoietic Cell Transplantation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mount Sinai Hospital, Canada</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mount Sinai Hospital, Canada</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hematologic malignancy patients are admitted to ICU in increasing numbers. Successful ICU
      intervention has led to an increasing number of ICU survivors; however, there is a lack of
      information available about these patients' long term survival and quality of life. There is
      little Canadian data regarding ICU survival and regarding 1-year survival and functional
      outcomes in this group of patients. Over 500 patients are admitted annually to Canadian ICUs
      with an underlying hematologic malignancy or stem cell transplant, yet there is a paucity of
      up to date long-term outcome data. This information will facilitate a better understanding
      who would best benefit from critical care interventions and the impact of critical illness on
      their level of function at 1 year as well as survival.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      At the time of ICU admission, the investigators will collect clinical data from the medical
      chart on a daily basis including demographics, pre-existing disease(s), treatment and reason
      for ICU admission.

      At the time of ICU discharge, the investigators will measure exercise tolerance and quality
      of life at 3 time intervals (Phase 2).

      For Phase 2, patients will be seen at day 7 following ICU discharge, 6 months following ICU
      discharge and 12 months after ICU discharge during their routine oncology follow up visits.
      During these visits, they will undergo a functional assessment (6 minute walk test) and
      questionnaires to determine their quality of life following ICU (validated outcome measures).

      All patients will complete outcome measures 1 to 5 below; Outcome measures 1 to 3 will be
      administered at 7 days and 1 to 5 at 6 months and 12 months after ICU discharge.

      Validated Outcomes Measures:

        1. Functional Independence Measure (FIM): a patient-centered measure of functional
           disability that captures burden of care on a daily basis and involves motor (FIM-motor)
           and cognitive function (FIM-cognition). FIM predicts disability outcome and
           rehabilitation needs in diverse patient populations.

        2. Six Minute Walk Test (6MWT) with continuous oximetry to measure the oxygen saturation of
           arterial blood will be performed to assess exercise capacity. It is simple to execute,
           inexpensive, standardized and gives a tangible measure of functional exercise capacity
           because it uses an exercise mode that is relevant to everyday activities.

        3. Clinical Frailty Scale (CFS): CFS is a 9-category tool ranging from 1 (Very fit) to 9
           (Terminally ill). It provides predictive information about death or need for an
           institution. It is easy to administer in less than 5 minutes.

        4. Medical Outcomes Study Short Form - 36 Questionnaire (SF-36): SF-36 evaluates 8 health
           concepts: physical functioning, role functioning-physical, bodily pain, general health,
           vitality, social functioning, role functioning- emotional, mental health and reported
           health transition. It has been validated in diverse patient populations and is a
           responsive and reproducible instrument; and can be completed in less than 15 minutes.

        5. FACT-BMT: A 47-item, valid and reliable measure of five dimensions of quality of life.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 26, 2018</start_date>
  <completion_date type="Anticipated">December 20, 2020</completion_date>
  <primary_completion_date type="Anticipated">May 20, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>1 year survival</measure>
    <time_frame>1 year</time_frame>
    <description>1 year survival in enrolled patients</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Intensive Care Unit survival</measure>
    <time_frame>1 year</time_frame>
    <description>ICU survival in enrolled patients</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>6 month functional outcome measured by the 6 minute walk test (6MWT)</measure>
    <time_frame>6 months</time_frame>
    <description>6MWT will be performed to assess exercise capacity at 6 months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>6 month Functional Independent Measure questionnaire (FIM)</measure>
    <time_frame>6 months</time_frame>
    <description>FIM: Captures burden of care on a daily basis and involves motor and cognitive function. FIM predicts disability outcome and rehabilitation needs.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>6 month Clinical Frailty Scale (CFS)</measure>
    <time_frame>6 months</time_frame>
    <description>CFS: Is a 9-category tool ranging from 1 (Very fit) to 9 (Terminally ill). It provides predictive information about death or need for an institution</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>6 month Short Form 36 Health Questionnaire (SF 36)</measure>
    <time_frame>6 months</time_frame>
    <description>SF-36: Evaluates 8 health concepts: physical functioning, role functioning-physical, bodily pain, general health, vitality, social functioning, role functioning- emotional, mental health and reported health transition.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>6 month Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT BMT)</measure>
    <time_frame>6 months</time_frame>
    <description>FACT-BMT: A 47-item, valid and reliable measure of five dimensions of quality of life.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>1 year functional outcome measured by the 6 minute walk test (6MWT)</measure>
    <time_frame>1 year</time_frame>
    <description>6MWT will be performed to assess exercise capacity at 6 months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>1 year Functional Independent Measure questionnaire (FIM)</measure>
    <time_frame>1 year</time_frame>
    <description>FIM: Captures burden of care on a daily basis and involves motor and cognitive function. FIM predicts disability outcome and rehabilitation needs.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>1 year Clinical Frailty Scale (CFS)</measure>
    <time_frame>1 year</time_frame>
    <description>CFS: Is a 9-category tool ranging from 1 (Very fit) to 9 (Terminally ill). It provides predictive information about death or need for an institution</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>1 year Short Form 36 Health Questionnaire (SF 36)</measure>
    <time_frame>1 year</time_frame>
    <description>SF-36: Evaluates 8 health concepts: physical functioning, role functioning-physical, bodily pain, general health, vitality, social functioning, role functioning- emotional, mental health and reported health transition.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>1 year Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT BMT)</measure>
    <time_frame>1 year</time_frame>
    <description>FACT-BMT: A 47-item, valid and reliable measure of five dimensions of quality of life.</description>
  </secondary_outcome>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Hematologic Malignancy</condition>
  <condition>Stem Cell Transplant</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with hematologic malignancy (HM) and hematopoietic cell transplantation (HCT)
        frequently develop life-threatening illness and require admission to an intensive care unit
        (ICU). In light of advancements in care and extension of treatments to much higher risk
        candidates, survival and functional outcome evaluation become crucial for informed
        development of practice guidelines to guide pre-ICU risk stratification, as well as ICU and
        post-ICU care. Robust and up to date long-term data on ICU morbidity and mortality outcomes
        are lacking.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects &gt;16 years with Hematologic Malignancy (HM) or post Stem Cell Transplant (HCT)
             who require ICU admission.

          -  HM includes: acute myeloid leukemia, acute lymphocytic leukemia, chronic myeloid
             leukemia, chronic lymphocytic leukemia, myeloma, lymphoma, myelofibrosis, and other
             myeloproliferative disorders or myelodysplastic syndromes.

          -  HCT is defined as the transplantation of multipotent hematopoietic stem cells from
             bone marrow, peripheral blood, or umbilical cord blood.

        Exclusion Criteria:

          -  Subjects with significant preexisting neurological or psychiatric disease will be
             excluded from Phase 2 (1-year follow-up) but will be included in Phase 1.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dr. Laveena Munshi, MD, FRCPC</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mount Sinai Hospital, New York</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Dr. Laveena Munshi, MD, FRCPC</last_name>
    <phone>416-586-4800</phone>
    <phone_ext>6571</phone_ext>
    <email>Laveena.Munshi@sinaihealthsystem.ca</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Dr. Sangeeta Mehta, MD, FRCPC</last_name>
    <phone>416-586-4800</phone>
    <phone_ext>4604</phone_ext>
    <email>geeta.mehta@utoronto.ca</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Foothills Hospital</name>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <zip>T2N 2T9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Paul Boiteau, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Alberta</name>
      <address>
        <city>Edmonton</city>
        <state>Alberta</state>
        <zip>T6G 2R3</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Nadia Baig</last_name>
    </contact>
    <investigator>
      <last_name>Sean Bagshaw, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Vancouver General Hospital</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <zip>V5Z 1M9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Michelle Storms</last_name>
    </contact>
    <investigator>
      <last_name>Donald Griesdale, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Manitoba</name>
      <address>
        <city>Winnipeg</city>
        <state>Manitoba</state>
        <zip>R3T 2N2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Nicole Marten</last_name>
    </contact>
    <contact_backup>
      <last_name>Justin Lys</last_name>
    </contact_backup>
    <investigator>
      <last_name>Ryan Zarychanski, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Queen Elizabeth II Health Sciences Centre</name>
      <address>
        <city>Halifax</city>
        <state>Nova Scotia</state>
        <zip>B3H 2Y9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Tamara Mitterer</last_name>
    </contact>
    <investigator>
      <last_name>Robert Green, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Royal Victoria Hospital</name>
      <address>
        <city>Barrie</city>
        <state>Ontario</state>
        <zip>L4M 6M2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Josie Campisi</last_name>
    </contact>
    <investigator>
      <last_name>Sheldon Magder, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Juravinski Hospital</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L8V 1C3</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Tina Millen, RRT</last_name>
    </contact>
    <investigator>
      <last_name>Bram Rochwerg, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kingston General Hospital</name>
      <address>
        <city>Kingston</city>
        <state>Ontario</state>
        <zip>K7L 2V7</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Miranda Hunt</last_name>
    </contact>
    <contact_backup>
      <last_name>Ilinca Georgescu</last_name>
    </contact_backup>
    <investigator>
      <last_name>Paul Heffernan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ottawa Hospital</name>
      <address>
        <city>Ottawa</city>
        <state>Ontario</state>
        <zip>K1H 8L6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Irene Watpool</last_name>
    </contact>
    <investigator>
      <last_name>Rakesh Patel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sunnybrook Health Sciences Centre</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M4N 3M5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Nicole Marinoff</last_name>
    </contact>
    <investigator>
      <last_name>Damon Scales, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mount Sinai Hospital</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5G 1X5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Prakruti Palepu</last_name>
      <phone>4165864800</phone>
    </contact>
    <investigator>
      <last_name>Sangeeta Mehta, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Health Network</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5G 2M9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Prakruthi Palepu</last_name>
    </contact>
    <investigator>
      <last_name>Santhosh Thyagu, MD, DM</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Maisonneuve-Rosemont Hospital</name>
      <address>
        <city>Montréal</city>
        <state>Quebec</state>
        <zip>H1T 2M4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Johanne Harvey</last_name>
    </contact>
    <contact_backup>
      <last_name>Danae Tassy</last_name>
    </contact_backup>
    <investigator>
      <last_name>Han Ting Wang, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <reference>
    <citation>Guidelines for intensive care unit admission, discharge, and triage. Task Force of the American College of Critical Care Medicine, Society of Critical Care Medicine. Crit Care Med. 1999 Mar;27(3):633-8.</citation>
    <PMID>10199547</PMID>
  </reference>
  <reference>
    <citation>Roze des Ordons AL, Chan K, Mirza I, Townsend DR, Bagshaw SM. Clinical characteristics and outcomes of patients with acute myelogenous leukemia admitted to intensive care: a case-control study. BMC Cancer. 2010 Sep 28;10:516. doi: 10.1186/1471-2407-10-516.</citation>
    <PMID>20920175</PMID>
  </reference>
  <reference>
    <citation>Cornish M, Butler MB, Green RS. Predictors of Poor Outcomes in Critically Ill Adults with Hematologic Malignancy. Can Respir J. 2016;2016:9431385. doi: 10.1155/2016/9431385. Epub 2016 Feb 24.</citation>
    <PMID>27445571</PMID>
  </reference>
  <reference>
    <citation>Kraguljac AP, Croucher D, Christian M, Ibrahimova N, Kumar V, Jacob G, Kiss A, Minden MD, Mehta S. Outcomes and Predictors of Mortality for Patients with Acute Leukemia Admitted to the Intensive Care Unit. Can Respir J. 2016;2016:3027656. doi: 10.1155/2016/3027656. Epub 2016 Jun 30.</citation>
    <PMID>27445524</PMID>
  </reference>
  <reference>
    <citation>Trinkaus MA, Lapinsky SE, Crump M, Keating A, Reece DE, Chen C, Hallett DC, Franke N, Winter A, Mikhael JR. Predictors of mortality in patients undergoing autologous hematopoietic cell transplantation admitted to the intensive care unit. Bone Marrow Transplant. 2009 Mar;43(5):411-5. doi: 10.1038/bmt.2008.336. Epub 2008 Oct 20.</citation>
    <PMID>18936734</PMID>
  </reference>
  <reference>
    <citation>Scales DC, Thiruchelvam D, Kiss A, Sibbald WJ, Redelmeier DA. Intensive care outcomes in bone marrow transplant recipients: a population-based cohort analysis. Crit Care. 2008;12(3):R77. doi: 10.1186/cc6923. Epub 2008 Jun 11.</citation>
    <PMID>18547422</PMID>
  </reference>
  <reference>
    <citation>Yadav H, Nolan ME, Bohman JK, Cartin-Ceba R, Peters SG, Hogan WJ, Gajic O, Kor DJ. Epidemiology of Acute Respiratory Distress Syndrome Following Hematopoietic Stem Cell Transplantation. Crit Care Med. 2016 Jun;44(6):1082-90. doi: 10.1097/CCM.0000000000001617.</citation>
    <PMID>26807683</PMID>
  </reference>
  <reference>
    <citation>Thakkar SG, Fu AZ, Sweetenham JW, Mciver ZA, Mohan SR, Ramsingh G, Advani AS, Sobecks R, Rybicki L, Kalaycio M, Sekeres MA. Survival and predictors of outcome in patients with acute leukemia admitted to the intensive care unit. Cancer. 2008 May 15;112(10):2233-40. doi: 10.1002/cncr.23394.</citation>
    <PMID>18348307</PMID>
  </reference>
  <reference>
    <citation>Cuthbertson BH, Rajalingam Y, Harrison S, McKirdy F, On behalf of the Scottish Intensive Care Society. The outcome of haematological malignancy in Scottish intensive care units. JICS 2008; 9 (2)</citation>
  </reference>
  <reference>
    <citation>Bird GT, Farquhar-Smith P, Wigmore T, Potter M, Gruber PC. Outcomes and prognostic factors in patients with haematological malignancy admitted to a specialist cancer intensive care unit: a 5 yr study. Br J Anaesth. 2012 Mar;108(3):452-9. doi: 10.1093/bja/aer449. Epub 2012 Jan 31. Review.</citation>
    <PMID>22298243</PMID>
  </reference>
  <reference>
    <citation>Hampshire PA, Pugh R, Hajimichael P. Outcomes for critically ill patients with haematological malignancies in specialist and non-specialist centres in the United Kingdom. Journal of Cancer Therapeutics &amp; Research 2014, http://www.hoajonline.com/journals/pdf/2049-7962-3-5.pdf</citation>
  </reference>
  <reference>
    <citation>Grgić Medić M, Gornik I, Gašparović V. Hematologic malignancies in the medical intensive care unit--Outcomes and prognostic factors. Hematology. 2015 Jun;20(5):247-53. doi: 10.1179/1607845414Y.0000000206. Epub 2014 Oct 13.</citation>
    <PMID>25310461</PMID>
  </reference>
  <reference>
    <citation>Azoulay E, Mokart D, Pène F, Lambert J, Kouatchet A, Mayaux J, Vincent F, Nyunga M, Bruneel F, Laisne LM, Rabbat A, Lebert C, Perez P, Chaize M, Renault A, Meert AP, Benoit D, Hamidfar R, Jourdain M, Darmon M, Schlemmer B, Chevret S, Lemiale V. Outcomes of critically ill patients with hematologic malignancies: prospective multicenter data from France and Belgium--a groupe de recherche respiratoire en réanimation onco-hématologique study. J Clin Oncol. 2013 Aug 1;31(22):2810-8. doi: 10.1200/JCO.2012.47.2365. Epub 2013 Jun 10.</citation>
    <PMID>23752112</PMID>
  </reference>
  <reference>
    <citation>Mokart D, Darmon M, Resche-Rigon M, Lemiale V, Pène F, Mayaux J, Rabbat A, Kouatchet A, Vincent F, Nyunga M, Bruneel F, Lebert C, Perez P, Renault A, Hamidfar R, Jourdain M, Meert AP, Benoit D, Chevret S, Azoulay E. Prognosis of neutropenic patients admitted to the intensive care unit. Intensive Care Med. 2015 Feb;41(2):296-303. doi: 10.1007/s00134-014-3615-y. Epub 2015 Jan 13.</citation>
    <PMID>25578678</PMID>
  </reference>
  <reference>
    <citation>Lengliné E, Chevret S, Moreau AS, Pène F, Blot F, Bourhis JH, Buzyn A, Schlemmer B, Socié G, Azoulay E. Changes in intensive care for allogeneic hematopoietic stem cell transplant recipients. Bone Marrow Transplant. 2015 Jun;50(6):840-5. doi: 10.1038/bmt.2015.55. Epub 2015 Mar 23.</citation>
    <PMID>25798675</PMID>
  </reference>
  <reference>
    <citation>Lemiale V, Resche-Rigon M, Mokart D, Pène F, Rabbat A, Kouatchet A, Vincent F, Bruneel F, Nyunga M, Lebert C, Perez P, Meert AP, Benoit D, Chevret S, Azoulay E. Acute respiratory failure in patients with hematological malignancies: outcomes according to initial ventilation strategy. A groupe de recherche respiratoire en réanimation onco-hématologique (Grrr-OH) study. Ann Intensive Care. 2015 Dec;5(1):28. doi: 10.1186/s13613-015-0070-z. Epub 2015 Sep 30.</citation>
    <PMID>26429355</PMID>
  </reference>
  <reference>
    <citation>Champigneulle B, Merceron S, Lemiale V, Geri G, Mokart D, Bruneel F, Vincent F, Perez P, Mayaux J, Cariou A, Azoulay E. What is the outcome of cancer patients admitted to the ICU after cardiac arrest? Results from a multicenter study. Resuscitation. 2015 Jul;92:38-44. doi: 10.1016/j.resuscitation.2015.04.011. Epub 2015 Apr 24.</citation>
    <PMID>25917260</PMID>
  </reference>
  <reference>
    <citation>Herridge MS, Chu LM, Matte A, Tomlinson G, Chan L, Thomas C, Friedrich JO, Mehta S, Lamontagne F, Levasseur M, Ferguson ND, Adhikari NK, Rudkowski JC, Meggison H, Skrobik Y, Flannery J, Bayley M, Batt J, Santos CD, Abbey SE, Tan A, Lo V, Mathur S, Parotto M, Morris D, Flockhart L, Fan E, Lee CM, Wilcox ME, Ayas N, Choong K, Fowler R, Scales DC, Sinuff T, Cuthbertson BH, Rose L, Robles P, Burns S, Cypel M, Singer L, Chaparro C, Chow CW, Keshavjee S, Brochard L, Hebert P, Slutsky AS, Marshall JC, Cook D, Cameron JI; RECOVER Program Investigators (Phase 1: towards RECOVER); Canadian Critical Care Trials Group. The RECOVER Program: Disability Risk Groups and 1-Year Outcome after 7 or More Days of Mechanical Ventilation. Am J Respir Crit Care Med. 2016 Oct 1;194(7):831-844.</citation>
    <PMID>26974173</PMID>
  </reference>
  <reference>
    <citation>Heyland DK, Garland A, Bagshaw SM, Cook D, Rockwood K, Stelfox HT, Dodek P, Fowler RA, Turgeon AF, Burns K, Muscedere J, Kutsogiannis J, Albert M, Mehta S, Jiang X, Day AG. Recovery after critical illness in patients aged 80 years or older: a multi-center prospective observational cohort study. Intensive Care Med. 2015 Nov;41(11):1911-20. doi: 10.1007/s00134-015-4028-2. Epub 2015 Aug 26.</citation>
    <PMID>26306719</PMID>
  </reference>
  <reference>
    <citation>Bekelman JE, Halpern SD, Blankart CR, Bynum JP, Cohen J, Fowler R, Kaasa S, Kwietniewski L, Melberg HO, Onwuteaka-Philipsen B, Oosterveld-Vlug M, Pring A, Schreyögg J, Ulrich CM, Verne J, Wunsch H, Emanuel EJ; International Consortium for End-of-Life Research (ICELR). Comparison of Site of Death, Health Care Utilization, and Hospital Expenditures for Patients Dying With Cancer in 7 Developed Countries. JAMA. 2016 Jan 19;315(3):272-83. doi: 10.1001/jama.2015.18603.</citation>
    <PMID>26784775</PMID>
  </reference>
  <reference>
    <citation>Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, Osborn TM, Nunnally ME, Townsend SR, Reinhart K, Kleinpell RM, Angus DC, Deutschman CS, Machado FR, Rubenfeld GD, Webb SA, Beale RJ, Vincent JL, Moreno R; Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013 Feb;41(2):580-637. doi: 10.1097/CCM.0b013e31827e83af.</citation>
    <PMID>23353941</PMID>
  </reference>
  <reference>
    <citation>Wise MP, Barnes RA, Baudouin SV, Howell D, Lyttelton M, Marks DI, Morris EC, Parry-Jones N; British Committee for Standards in Haematology. Guidelines on the management and admission to intensive care of critically ill adult patients with haematological malignancy in the UK. Br J Haematol. 2015 Aug 19. doi: 10.1111/bjh.13594. [Epub ahead of print]</citation>
    <PMID>26287443</PMID>
  </reference>
  <reference>
    <citation>Mehta S, Burry L, Cook D, Fergusson D, Steinberg M, Granton J, Herridge M, Ferguson N, Devlin J, Tanios M, Dodek P, Fowler R, Burns K, Jacka M, Olafson K, Skrobik Y, Hébert P, Sabri E, Meade M; SLEAP Investigators; Canadian Critical Care Trials Group. Daily sedation interruption in mechanically ventilated critically ill patients cared for with a sedation protocol: a randomized controlled trial. JAMA. 2012 Nov 21;308(19):1985-92. Erratum in: JAMA. 2013 Jan 16;309(3):237.</citation>
    <PMID>23180503</PMID>
  </reference>
  <reference>
    <citation>Bell C, Liu J, Debacker J, Tamberg E, Campbell V, Lee C, Mehta S. Noninvasive ventilation in patients with haematologic malignancy: a retrospective review. Critical Care 2016; 20 (Suppl 2): P234.</citation>
  </reference>
  <reference>
    <citation>MacEachern KN, Kraguljac AP, Mehta S. Nutrition care of critically ill patients with leukemia: a retrospective review. Intensive Care Med 2014;40(1):S0286.</citation>
  </reference>
  <reference>
    <citation>Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-83.</citation>
    <PMID>3558716</PMID>
  </reference>
  <reference>
    <citation>Vincent JL, Moreno R, Takala J, Willatts S, De Mendonça A, Bruining H, Reinhart CK, Suter PM, Thijs LG. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996 Jul;22(7):707-10.</citation>
    <PMID>8844239</PMID>
  </reference>
  <reference>
    <citation>Oczkowski WJ, Barreca S. The functional independence measure: its use to identify rehabilitation needs in stroke survivors. Arch Phys Med Rehabil. 1993 Dec;74(12):1291-4.</citation>
    <PMID>8259894</PMID>
  </reference>
  <reference>
    <citation>Enright PL, Sherrill DL. Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med. 1998 Nov;158(5 Pt 1):1384-7.</citation>
    <PMID>9817683</PMID>
  </reference>
  <reference>
    <citation>Ware JE J, Kosinski M, Gandek B. SF-36 Health Survey: manual and interpretation guide. Lincoln,R.I.: QualityMetric Inc.; 2002.</citation>
  </reference>
  <reference>
    <citation>Rockwood K, Song X, MacKnight C, Bergman H, Hogan DB, McDowell I, Mitnitski A. A global clinical measure of fitness and frailty in elderly people. CMAJ. 2005 Aug 30;173(5):489-95.</citation>
    <PMID>16129869</PMID>
  </reference>
  <reference>
    <citation>McQuellon RP, Russell GB, Cella DF, Craven BL, Brady M, Bonomi A, Hurd DD. Quality of life measurement in bone marrow transplantation: development of the Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT-BMT) scale. Bone Marrow Transplant. 1997 Feb;19(4):357-68.</citation>
    <PMID>9051246</PMID>
  </reference>
  <reference>
    <citation>Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ. 2002 Mar;21(2):271-92.</citation>
    <PMID>11939242</PMID>
  </reference>
  <reference>
    <citation>Ferguson ND, Scales DC, Pinto R, Wilcox ME, Cook DJ, Guyatt GH, Schünemann HJ, Marshall JC, Herridge MS, Meade MO; Canadian Critical Care Trials Group. Integrating mortality and morbidity outcomes: using quality-adjusted life years in critical care trials. Am J Respir Crit Care Med. 2013 Feb 1;187(3):256-61. doi: 10.1164/rccm.201206-1057OC. Epub 2012 Nov 29.</citation>
    <PMID>23204250</PMID>
  </reference>
  <reference>
    <citation>Bender JM, Ampofo K, Gesteland P, Stoddard GJ, Nelson D, Byington CL, Pavia AT, Srivastava R. Development and validation of a risk score for predicting hospitalization in children with influenza virus infection. Pediatr Emerg Care. 2009 Jun;25(6):369-75. doi: 10.1097/PEC.0b013e3181a792a9.</citation>
    <PMID>19458562</PMID>
  </reference>
  <reference>
    <citation>Sullivan LM, Massaro JM, D'Agostino RB Sr. Presentation of multivariate data for clinical use: The Framingham Study risk score functions. Stat Med. 2004 May 30;23(10):1631-60. Review.</citation>
    <PMID>15122742</PMID>
  </reference>
  <reference>
    <citation>Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology. 1983 Sep;148(3):839-43.</citation>
    <PMID>6878708</PMID>
  </reference>
  <reference>
    <citation>Herridge MS, Cheung AM, Tansey CM, Matte-Martyn A, Diaz-Granados N, Al-Saidi F, Cooper AB, Guest CB, Mazer CD, Mehta S, Stewart TE, Barr A, Cook D, Slutsky AS; Canadian Critical Care Trials Group. One-year outcomes in survivors of the acute respiratory distress syndrome. N Engl J Med. 2003 Feb 20;348(8):683-93.</citation>
    <PMID>12594312</PMID>
  </reference>
  <reference>
    <citation>Herridge MS, Tansey CM, Matté A, Tomlinson G, Diaz-Granados N, Cooper A, Guest CB, Mazer CD, Mehta S, Stewart TE, Kudlow P, Cook D, Slutsky AS, Cheung AM; Canadian Critical Care Trials Group. Functional disability 5 years after acute respiratory distress syndrome. N Engl J Med. 2011 Apr 7;364(14):1293-304. doi: 10.1056/NEJMoa1011802.</citation>
    <PMID>21470008</PMID>
  </reference>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 23, 2017</study_first_submitted>
  <study_first_submitted_qc>February 22, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">February 28, 2018</study_first_posted>
  <last_update_submitted>April 23, 2018</last_update_submitted>
  <last_update_submitted_qc>April 23, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 25, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

